CRISPR patent fight continues. How it impacts science and medical innovation

Credit: Northern California Record
Credit: Northern California Record

Legal wrangling is complicating life for those who want to use [CRISPR technology] to develop commercial products.

At issue is the fact that the patent landscape for CRISPR-Cas9 is likely to remain complicated and dynamic for years to come, as more patent applications are examined, granted, opposed or revoked in different jurisdictions. The outcome of these patent disputes could have a major impact on the innovation and commercialization of CRISPR-Cas9, as well as on the public interest and social responsibility of using this powerful technology.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

However, the ownership and licensing of this technology is also a source of legal disputes and controversies among various parties. Anyone who thought gene editing would level the playing field and open a world of new breeding possibilities free from the high costs of working in the GM space might want to think again, thanks to the complicated world of gene editing patents.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.